What Drug Classification is Emtricitabine? A Closer Look at its Role as a Nucleoside Reverse Transcriptase Inhibitor
•
4 min read
First approved by the FDA in 2003, emtricitabine (FTC) is a nucleoside reverse transcriptase inhibitor (NRTI). This classification places it among the essential antiretroviral drugs used in combination to treat and prevent HIV infection, leveraging its unique mechanism to block viral replication.
